Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 7658970, 9 pages
https://doi.org/10.1155/2017/7658970
Research Article

Expression and Immunogenicity of Two Recombinant Fusion Proteins Comprising Foot-and-Mouth Disease Virus Structural Protein VP1 and DC-SIGN-Binding Glycoproteins

1State Key Laboratory of Veterinary Etiological Biology, OIE/National Foot and Mouth Disease Reference Laboratory, Key Laboratory of Animal Virology of Ministry of Agriculture, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China
2Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, China
3College of Veterinary Medicine, Gansu Agricultural University, Lanzhou, Gansu 730070, China

Correspondence should be addressed to Yongguang Zhang; nc.saac@gnauggnoygnahz and Yonglu Wang; moc.liamtoh@dmulgnoygnaw

Received 29 April 2017; Revised 22 August 2017; Accepted 28 August 2017; Published 8 October 2017

Academic Editor: Marcelo A. Soares

Copyright © 2017 Xinsheng Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Grubman and B. Baxt, “Foot-and-mouth disease,” Clinical Microbiology Reviews, vol. 17, no. 2, pp. 465–493, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. S. M. Jamal and G. J. Belsham, “Foot-and-mouth disease: past, present and future,” Veterinary Research, vol. 44, no. 1, article 116, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Cao, Z. Lu, and Z. Liu, “Foot-and-mouth disease vaccines: progress and problems,” Expert Review of Vaccines, vol. 15, no. 6, pp. 783–789, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. L. L. Rodriguez and C. G. Gay, “Development of vaccines toward the global control and eradication of foot-and-mouth disease,” Expert Review of Vaccines, vol. 10, no. 3, pp. 377–387, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. O. P. Joffre, E. Segura, A. Savina, and S. Amigorena, “Cross-presentation by dendritic cells,” Nature Reviews Immunology, vol. 12, no. 8, pp. 557–569, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Dresch, Y. Leverrier, J. Marvel, and K. Shortman, “Development of antigen cross-presentation capacity in dendritic cells,” Trends in Immunology, vol. 33, no. 8, pp. 381–388, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Caminschi and K. Shortman, “Boosting antibody responses by targeting antigens to dendritic cells,” Trends in Immunology, vol. 33, no. 2, pp. 71–77, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. van Kooyk, W. W. J. Unger, C. M. Fehres, H. Kalay, and J. J. García-Vallejo, “Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation,” Molecular Immunology, vol. 55, no. 2, pp. 143–145, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. A. Bashirova, L. Wu, J. Cheng et al., “Novel member of the CD209 (DC-SIGN) gene family in primates,” Journal of Virology, vol. 77, no. 1, pp. 217–227, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. J. J. García-Vallejo, W. W. J. Unger, H. Kalay, and Y. van Kooyk, “Glycan-based DC-SIGN targeting to enhance antigen cross-presentation in anticancer vaccines,” OncoImmunology, vol. 2, no. 2, Article ID e23040, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. L. J. Cruz, P. J. Tacken, J. M. Pots, R. Torensma, S. I. Buschow, and C. G. Figdor, “Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN,” Biomaterials, vol. 33, no. 16, pp. 4229–4239, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Liu, J. Wang, Y. Yang, I. Khan, Y. Dong, and N. Zhu, “A novel rabies virus lipopeptide provides a better protection by improving the magnitude of DCs activation and T cell responses,” Virus Research, vol. 221, pp. 66–73, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Pecora, D. A. Malacari, M. S. Perez Aguirreburualde et al., “Development of an APC-targeted multivalent E2-based vaccine against Bovine Viral Diarrhea Virus types 1 and 2,” Vaccine, vol. 33, no. 39, pp. 5163–5171, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. U. Švajger, M. Anderluh, M. Jeras, and N. Obermajer, “C-type lectin DC-SIGN: An adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity,” Cellular Signalling, vol. 22, no. 10, pp. 1397–1405, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. K. Khattar, S. Samal, C. C. LaBranche, D. C. Montefiori, P. L. Collins, and S. K. Samal, “Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated newcastle disease virus vector,” PLoS ONE, vol. 8, no. 10, Article ID e78521, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. S. V. Su, P. Hong, S. Baik, O. A. Negrete, K. B. Gurney, and B. Lee, “DC-SIGN binds to HIV-1 glycoprotein 120 in a distinct but overlapping fashion compared with ICAM-2 and ICAM-3,” Journal of Biological Chemistry, vol. 279, no. 18, pp. 19122–19132, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. L.-J. Zhao, W. Wang, H. Ren, and Z.-T. Qi, “ERK signaling is triggered by hepatitis C virus E2 protein through DC-SIGN,” Cell Stress and Chaperones, vol. 18, no. 4, pp. 495–501, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Pöhlmann, J. Zhang, F. Baribaud et al., “Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR,” Journal of Virology, vol. 77, no. 7, pp. 4070–4080, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. OIE, OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Foot-and-mouth disease, 2009, http://www.oie.int/eng/A_FMD2012/docs/2.01.05_FMD.pdf.
  20. S. N. Beljelarskaya, “Baculovirus expression systems for production of recombinant proteins in insect and mammalian cells,” Molecular Biology, vol. 45, no. 1, pp. 123–138, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. N. N. Koroleva, P. V. Spirin, A. V. Timokhova et al., “Baculovirus vectors for efficient gene delivery and expression in mammalian cells,” Molecular Biology, vol. 44, no. 3, pp. 479–487, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Zheng, C. L. Liu, J. Zhuang, and S. S. Yuan, “Baculovirus expression of cloned porcine arterivirus generates infectious particles in both insect and mammalian cells,” Journal of Biotechnology, vol. 150, no. 2, pp. 251–258, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. F. M. Boyce and N. L. R. Bucher, “Baculovirus-mediated gene transfer into mammalian cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 6, pp. 2348–2352, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Diaz-San Segundo, G. N. Medina, C. Stenfeldt, J. Arzt, and T. de los Santos, “Foot-and-mouth disease vaccines,” Veterinary Microbiology, vol. 206, pp. 102–112, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. J. Du, P. Jiang, Y. F. Li et al., “Immune responses of two recombinant adenoviruses expressing VP1 antigens of FMDV fused with porcine granulocyte macrophage colony-stimulating factor,” Vaccine, vol. 25, no. 49, pp. 8209–8219, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Pan, Y. G. Zhang, Y. L. Wang, J. L. Lv, P. Zhou, and Z. W. Zhang, “Expression and detection of the FMDV VP1 transgene and expressed structural protein in Arabidopsis thaliana,” Turkish Journal of Veterinary and Animal, vol. 35, no. 4, pp. 235–242, 2011. View at Google Scholar
  27. J. P. Rao, P. Agrawal, R. Mohammad et al., “Expression of VP1 protein of serotype A and O of foot-and-mouth disease virus in transgenic sunnhemp plants and its immunogenicity for guinea pigs,” Acta Virologica, vol. 56, no. 2, pp. 91–99, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Wang, L. Pan, P. Zhou et al., “Protection against foot-and-mouth disease virus in Guinea pigs via oral administration of recombinant Lactobacillus plantarum expressing VP1,” PLoS ONE, vol. 10, no. 12, Article ID e0143750, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. C. S. Yin, W. Y. Chen, Q. Q. Hu et al., “Induction of protective immune response against both PPRV and FMDV by a novel recombinant PPRV expressing FMDV VP1,” Veterinary Research, vol. 45, no. 1, article 62, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. L. Wang, Y. H. Mao, X. D. Xu, S. H. Tao, and H. Y. Chen, “Codon usage in signal sequences affects protein expression and secretion using baculovirus/insect cell expression system,” PLoS ONE, vol. 10, no. 12, Article ID e0145887, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Buchan and I. Stansfield, “Codon pair bias in prokaryotic and eukaryotic genomes,” BMC Bioinformatics, vol. 6, 2005. View at Publisher · View at Google Scholar
  32. Z. P. Zhoua, Y. K. Danga, M. Zhou et al., “Codon usage is an important determinant of gene expression levels largely through its effects on transcription,” Proceedings of the National Academy of Sciences of the United States of America, vol. 113, no. 41, pp. E6117–E6125, 2016. View at Publisher · View at Google Scholar · View at Scopus